Literature DB >> 30219581

Therapeutic potential of curcumin in diabetic complications.

Negin Parsamanesh1, Maryam Moossavi1, Afsane Bahrami2, Alexandra E Butler3, Amirhossein Sahebkar4.   

Abstract

Diabetes mellitus is an extremely prevalent endocrine disease and a major global public health concern. Diabetic complications, such as retinopathy, nephropathy, neuropathy and cardiovascular disease, are common and majorly impact a patient's quality of life. Curcumin, the major active component of turmeric, possesses extensive known pharmacological properties, including anti-inflammatory, antioxidant, and antitumor effects. Increasing evidence suggests that curcumin may offer protection against diabetic complications. The current review focuses on the possible molecular targets and pathways involved in diabetic complications and, in particular, the multi-target approach of curcumin in attenuating diabetic nephropathy, retinopathy, and neuropathy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic cardiomyopathy; Diabetic nephropathy; Diabetic neuropathy; Diabetic retinopathy

Mesh:

Substances:

Year:  2018        PMID: 30219581     DOI: 10.1016/j.phrs.2018.09.012

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  26 in total

1.  Boosting GLP-1 by Natural Products.

Authors:  Habib Yaribeygi; Tannaz Jamialahmadi; Seyed Adel Moallem; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms.

Authors:  Roghaye Gharaei; Forough Mahdavinezhad; Esmaeil Samadian; Jahanbakhsh Asadi; Zhaleh Ashrafnezhad; Ladan Kashani; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2021-11       Impact factor: 3.412

Review 3.  Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology.

Authors:  Malihe Mohamadian; Seyed Sajad Ahmadi; Afsane Bahrami; Gordon A Ferns
Journal:  Neurochem Res       Date:  2022-07-05       Impact factor: 4.414

Review 4.  Antidiabetic Properties of Curcumin: Insights on New Mechanisms.

Authors:  Elahe Mohammadi; Behzad Behnam; Reza Mohammadinejad; Paul C Guest; Luis E Simental-Mendía; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Development of Gelucire® 48/16 and TPGS Mixed Micelles and Its Pellet Formulation by Extrusion Spheronization Technique for Dissolution Rate Enhancement of Curcumin.

Authors:  Umesh K Shinde; Dilipkumar G Suryawanshi; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2021-06-15       Impact factor: 3.246

6.  IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis.

Authors:  Chengcheng Song; Shuqiang Wang; Zhangning Fu; Kun Chi; Xiaodong Geng; Chao Liu; Guangyan Cai; Xiangmei Chen; Di Wu; Quan Hong
Journal:  Cell Death Dis       Date:  2022-04-13       Impact factor: 8.469

Review 7.  The potential health benefits of dietary natural plant products in age related eye diseases.

Authors:  Eleazar Uchenna Ikonne; Victor Okezie Ikpeazu; Eziuche Amadike Ugbogu
Journal:  Heliyon       Date:  2020-07-10

8.  Natural Deep Eutectic Solvents as Agents for Improving Solubility, Stability and Delivery of Curcumin.

Authors:  Tomasz Jeliński; Maciej Przybyłek; Piotr Cysewski
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

Review 9.  Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.

Authors:  Yujiao Zheng; Xiaowen Gou; Lili Zhang; Hanjia Gao; Yu Wei; Xiaotong Yu; Bing Pang; Jiaxing Tian; Xiaolin Tong; Min Li
Journal:  Front Cell Infect Microbiol       Date:  2020-07-17       Impact factor: 5.293

10.  Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.

Authors:  Qiudi Tu; Yiwen Li; Juan Jin; Xinxin Jiang; Yan Ren; Qiang He
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.